Atlas Trials

High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements

RecordFirmDate
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275)National Cancer Institute (NCI)2021-05-20
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma (NCT04323956)Mayo Clinic2020-06-15
Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT02199184)M.D. Anderson Cancer Center2015-01-14

Track High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements automatically

Every clearance here is in the API, with alerts when new ones post.